Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4.
Toll-like receptor 4
cardiac hypertrophy
immune response
inflammation
signaling pathway
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
07
2020
accepted:
02
11
2020
entrez:
16
12
2020
pubmed:
17
12
2020
medline:
17
12
2020
Statut:
epublish
Résumé
Toll-like receptor 4 (TLR4), a key pattern recognition receptor, initiates the innate immune response and leads to chronic and acute inflammation. In the past decades, accumulating evidence has implicated TLR4-mediated inflammatory response in regulation of myocardium hypertrophic remodeling, indicating that regulation of the TLR4 signaling pathway may be an effective strategy for managing cardiac hypertrophy's pathophysiology. Given TLR4's significance, it is imperative to review the molecular mechanisms and roles underlying TLR4 signaling in cardiac hypertrophy. Here, we comprehensively review the current knowledge of TLR4-mediated inflammatory response and its interaction ligands and co-receptors, as well as activation of various intracellular signaling. We also describe the associated roles in promoting immune cell infiltration and inflammatory mediator secretion, that ultimately cause cardiac hypertrophy. Finally, we provide examples of some of the most promising drugs and new technologies that have the potential to attenuate TLR4-mediated inflammatory response and prevent or reverse the ominous cardiac hypertrophy outcomes.
Identifiants
pubmed: 33324685
doi: 10.3389/fcvm.2020.579036
pmc: PMC7725871
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
579036Informations de copyright
Copyright © 2020 Xiao, Kong, Yang, Dai, Fang, Qin and Huang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Cell Physiol. 2019 Aug;234(10):18731-18747
pubmed: 30953351
Nat Rev Cardiol. 2018 Jul;15(7):387-407
pubmed: 29674714
Sci Rep. 2017 Jul 11;7(1):5116
pubmed: 28698617
Circulation. 2014 May 27;129(21):2111-24
pubmed: 24657994
Lab Invest. 2020 Mar;100(3):378-386
pubmed: 31527830
Am J Cardiol. 1999 Jun 17;83(12A):53H-57H
pubmed: 10750588
Mol Immunol. 2016 Jun;74:96-105
pubmed: 27174187
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1894-903
pubmed: 26775585
J Cardiovasc Pharmacol. 2017 Oct;70(4):245-254
pubmed: 28662005
J Hypertens. 2015 Jan;33(1):144-52
pubmed: 25304471
J Cardiovasc Pharmacol. 2017 Aug;70(2):61-73
pubmed: 28763371
JACC Basic Transl Sci. 2019 Apr 29;4(2):234-247
pubmed: 31061925
J Leukoc Biol. 2016 Jul;100(1):27-45
pubmed: 27162325
Adv Exp Med Biol. 2017;1000:187-210
pubmed: 29098623
Autoimmun Rev. 2019 Jul;18(7):738-748
pubmed: 31059845
Cells. 2019 Oct 09;8(10):
pubmed: 31600901
Mol Med. 2013 Feb 08;18:1509-18
pubmed: 23269975
Cardiovasc Toxicol. 2020 Jun;20(3):235-248
pubmed: 31485892
Cells. 2020 Jan 15;9(1):
pubmed: 31952223
Am J Physiol Heart Circ Physiol. 2019 Dec 1;317(6):H1301-H1311
pubmed: 31729904
Am J Physiol Regul Integr Comp Physiol. 2014 Sep 1;307(5):R501-4
pubmed: 24920728
J Cell Mol Med. 2015 Dec;19(12):2728-40
pubmed: 26290459
J Pharm Pharmacol. 2018 Nov;70(11):1521-1530
pubmed: 30175489
Cardiovasc Res. 2019 Mar 1;115(3):614-624
pubmed: 30295707
J Leukoc Biol. 2009 Jun;85(6):966-77
pubmed: 19289601
Circulation. 2001 Apr 3;103(13):1787-92
pubmed: 11282911
J Thorac Dis. 2015 Oct;7(10):1787-97
pubmed: 26623102
Heart Fail Rev. 2007 Mar;12(1):66-86
pubmed: 17387610
Biosci Rep. 2018 Feb 12;:
pubmed: 29440460
Scand J Clin Lab Invest. 2020 May;80(3):236-246
pubmed: 32057259
Mol Cell Ther. 2015 May 30;3:4
pubmed: 26056605
Arq Bras Cardiol. 2017 Apr;108(4):331-338
pubmed: 28380135
Endocrinology. 2016 Jun;157(6):2282-93
pubmed: 27100622
J Mol Cell Cardiol. 2019 Apr;129:293-302
pubmed: 30641087
Eur J Med Chem. 2018 Jun 25;154:253-266
pubmed: 29807331
Cardiovasc Toxicol. 2017 Oct;17(4):458-470
pubmed: 28220374
Eur J Pharmacol. 2018 Jan 5;818:508-517
pubmed: 29157986
Biochem Biophys Res Commun. 2014 Mar 28;446(1):292-7
pubmed: 24582748
Clin Sci (Lond). 2008 Oct;115(7):203-18
pubmed: 18752467
Curr Hypertens Rep. 2018 Oct 5;20(12):100
pubmed: 30291560
J Hypertens. 2009 May;27(5):1084-93
pubmed: 19342961
Vaccines (Basel). 2017 Oct 04;5(4):
pubmed: 28976923
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
Immunity. 2017 Jan 17;46(1):38-50
pubmed: 27986454
Basic Res Cardiol. 2006 Sep;101(5):427-35
pubmed: 16699746
Int J Mol Med. 2018 Sep;42(3):1436-1444
pubmed: 29845292
J Mol Cell Cardiol. 2018 Aug;121:306
pubmed: 29729805
Int J Cardiol. 2017 Jun 15;237:60-63
pubmed: 28285801
Antioxid Redox Signal. 2011 Oct 1;15(7):1895-909
pubmed: 21126202
Hypertension. 2017 Jul;70(1):137-147
pubmed: 28559389
Thromb Haemost. 2008 Aug;100(2):301-7
pubmed: 18690351
BMB Rep. 2017 Feb;50(2):55-57
pubmed: 28115037
Clin Sci (Lond). 2011 Jul;121(1):1-10
pubmed: 21413930
Expert Rev Cardiovasc Ther. 2015;13(7):743-51
pubmed: 26028173
Int J Mol Sci. 2019 Aug 08;20(16):
pubmed: 31398927
Int J Mol Sci. 2019 Jun 26;20(13):
pubmed: 31247943
Basic Res Cardiol. 2020 Feb 1;115(2):19
pubmed: 32008145
Int J Mol Med. 2019 Sep;44(3):885-892
pubmed: 31524228
Nat Rev Immunol. 2013 Jun;13(6):453-60
pubmed: 23681101
Int J Mol Sci. 2019 Sep 06;20(18):
pubmed: 31489895
Transplant Proc. 2020 Jul - Aug;52(6):1869-1874
pubmed: 32631581
J Hypertens. 2015 Apr;33(4):773-83; discussion 783
pubmed: 25915882
J Mol Cell Cardiol. 2015 Sep;86:158-67
pubmed: 26239133
Biochem Biophys Res Commun. 2020 Mar 19;523(4):867-873
pubmed: 31955888
Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H552-H562
pubmed: 29196344
Lab Invest. 2012 Nov;92(11):1518-26
pubmed: 22825686
J Med Chem. 2011 Jul 14;54(13):4659-69
pubmed: 21591694
J Cell Mol Med. 2016 Mar;20(3):459-70
pubmed: 26647902
Atherosclerosis. 2018 Dec;279:23-31
pubmed: 30399463
Pharmacol Res. 2015 Nov;101:30-40
pubmed: 26151416
Int J Mol Med. 2018 Jun;41(6):3287-3295
pubmed: 29512709
J Clin Invest. 2019 Feb 26;129(6):2293-2304
pubmed: 30830879
J Mol Cell Cardiol. 2016 Aug;97:245-62
pubmed: 27262674
Circ Res. 2009 Nov 20;105(11):1149-58
pubmed: 19834007
Biochem Biophys Res Commun. 2017 Nov 18;493(2):1151-1158
pubmed: 28698147
J Mol Cell Cardiol. 2016 Oct 27;:
pubmed: 27983968
Clin Dev Immunol. 2012;2012:836485
pubmed: 22737174
Curr Opin Hematol. 2018 Jan;25(1):44-51
pubmed: 28914666
Genomics. 2010 Aug;96(2):73-81
pubmed: 20417270
J Cell Mol Med. 2019 Aug;23(8):5303-5316
pubmed: 31140723
J Immunol. 2008 Jun 1;180(11):7349-57
pubmed: 18490734
Zhonghua Yi Xue Za Zhi. 2005 Jan 26;85(4):267-72
pubmed: 15854490
Cardiovasc Res. 2019 Jun 1;115(7):1205-1216
pubmed: 30753344
J Mol Cell Cardiol. 2012 May;52(5):1135-44
pubmed: 22326848
Am J Physiol Cell Physiol. 2004 Apr;286(4):C739-44
pubmed: 15001423
PLoS One. 2016 Apr 12;11(4):e0152922
pubmed: 27070323
Cardiovasc Res. 2014 Jul 1;103(1):17-27
pubmed: 24667851
Circulation. 2007 Mar 20;115(11):1398-407
pubmed: 17353445
Toxicol Appl Pharmacol. 2016 Aug 15;305:93-102
pubmed: 27292124
J Atheroscler Thromb. 2015 Aug 26;22(8):833-44
pubmed: 25752363
J Cardiovasc Pharmacol. 2020 Jul;76(1):63-70
pubmed: 32398475
Nat Commun. 2017 Mar 06;8:14680
pubmed: 28262700
Cardiovasc Res. 2019 Jun 1;115(7):1244-1255
pubmed: 30851101
Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):991-998
pubmed: 31353205
Cardiovasc Res. 2006 Feb 1;69(2):318-28
pubmed: 16289003
Hypertens Res. 2011 May;34(5):551-8
pubmed: 21248757
PLoS One. 2016 Jun 29;11(6):e0158514
pubmed: 27355349
Curr Pharm Des. 2011;17(18):1818-24
pubmed: 21631421
J Cardiovasc Pharmacol. 2016 Oct;68(4):257-264
pubmed: 27195652
Int J Nanomedicine. 2017 Jul 03;12:4709-4719
pubmed: 28740379
Immunol Lett. 2009 Jun 30;125(1):31-9
pubmed: 19501120
PLoS One. 2015 Sep 17;10(9):e0138372
pubmed: 26378790
Am J Physiol Cell Physiol. 2006 Mar;290(3):C917-24
pubmed: 16267105
Cardiovasc Res. 2005 Nov 1;68(2):224-34
pubmed: 15967420
Eur J Heart Fail. 2011 Jun;13(6):602-10
pubmed: 21613426
Arch Toxicol. 2015 Sep;89(9):1401-38
pubmed: 25708889
J Mol Cell Cardiol. 2010 Sep;49(3):499-507
pubmed: 20488188
J Neuroinflammation. 2015 Feb 18;12:31
pubmed: 25879545
Circ Res. 2016 Jun 10;118(12):1918-1929
pubmed: 27126808
Hypertension. 2015 Sep;66(3):647-56
pubmed: 26195481
Biochem Biophys Res Commun. 2017 Dec 16;494(3-4):534-541
pubmed: 29079193
Food Funct. 2016 Jan;7(1):584-93
pubmed: 26593388
Circulation. 2015 Mar 17;131(11):1019-30
pubmed: 25779542
J Mol Med (Berl). 2017 Jun;95(6):671-682
pubmed: 28161820
Nat Commun. 2017 Jan 03;8:13997
pubmed: 28045026
Cardiovasc Res. 2014 Jul 1;103(1):3-4
pubmed: 24835276
Curr Cardiol Rep. 2018 Sep 26;20(11):117
pubmed: 30259192
Arch Toxicol. 2015 Jun;89(6):867-82
pubmed: 25690731
Sci Rep. 2017 Feb 06;7:41857
pubmed: 28165494
Circ Res. 2014 Jan 31;114(3):565-71
pubmed: 24481846
Can J Cardiol. 2019 Feb;35(2):208-216
pubmed: 30760428
Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):252-262
pubmed: 28965884
J Mol Biol. 2008 Jan 18;375(3):637-49
pubmed: 18037434
Front Immunol. 2017 Jun 22;8:719
pubmed: 28690610
Eur J Pharmacol. 2019 Feb 5;844:79-86
pubmed: 30458167
Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H985-94
pubmed: 16199478
Circ Heart Fail. 2015 Jul;8(4):776-87
pubmed: 26022677
Cell Death Dis. 2016 May 26;7:e2234
pubmed: 27228349
J Mol Med (Berl). 2011 Jun;89(6):537-43
pubmed: 21279501
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1236-H1249
pubmed: 30095997
Braz J Med Biol Res. 2019;52(7):e8732
pubmed: 31314855
Hypertension. 2019 Oct;74(4):843-853
pubmed: 31476902
J Hypertens. 2018 Apr;36(4):847-856
pubmed: 29283973
Circulation. 2017 Apr 11;135(15):1444-1457
pubmed: 28174192
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 19;373(1738):
pubmed: 29203707
Cardiovasc Res. 2013 Sep 1;99(4):657-64
pubmed: 23708738
Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H1027-H1038
pubmed: 30793936
Expert Opin Ther Targets. 2011 Jun;15(6):753-65
pubmed: 21385118
Hypertension. 2003 Mar;41(3 Pt 2):819-23
pubmed: 12624002
Eur J Immunol. 2015 Feb;45(2):356-70
pubmed: 25476977
PLoS One. 2015 Nov 20;10(11):e0142921
pubmed: 26588247
J Clin Invest. 2009 Apr;119(4):986-96
pubmed: 19273909
Mol Cell Biochem. 2017 May;429(1-2):167-177
pubmed: 28176246
J Cell Biochem. 2019 Oct;120(10):16703-16710
pubmed: 31081962
J Leukoc Biol. 2007 Jan;81(1):1-5
pubmed: 17032697
J Biomed Sci. 2017 Feb 7;24(1):13
pubmed: 28173864
Cardiovasc Res. 2010 Oct 1;88(1):140-9
pubmed: 20542874
Basic Res Cardiol. 2017 Jan;112(1):9
pubmed: 28013347
PLoS One. 2015 Oct 08;10(10):e0139350
pubmed: 26448184
Circ Res. 2015 Mar 27;116(7):1269-76
pubmed: 25814687
Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):831-842
pubmed: 29222072
World J Cardiol. 2016 May 26;8(5):340-50
pubmed: 27231521
J Exp Med. 2015 Jan 12;212(1):5-14
pubmed: 25559892
Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1712-20
pubmed: 15142841
J Mol Cell Cardiol. 2016 May;94:189-200
pubmed: 26542796